Strobeck MW - Search Results

1

Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates.

Berndt ER, Gottschalk AH, Philipson TJ, Strobeck MW. Berndt ER, et al. Among authors: strobeck mw. Nat Rev Drug Discov. 2005 Jul;4(7):545-54. doi: 10.1038/nrd1774. Nat Rev Drug Discov. 2005. PMID: 16052239 Review.

2

Multiple myeloma therapies.

Strobeck M. Strobeck M. Nat Rev Drug Discov. 2007 Mar;6(3):181-2. doi: 10.1038/nrd2269. Nat Rev Drug Discov. 2007. PMID: 17396289 No abstract available.

3

Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.

Markey MP, Angus SP, Strobeck MW, Williams SL, Gunawardena RW, Aronow BJ, Knudsen ES. Markey MP, et al. Among authors: strobeck mw. Cancer Res. 2002 Nov 15;62(22):6587-97. Cancer Res. 2002. PMID: 12438254

4

Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB.

Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. Betz BL, et al. Among authors: strobeck mw. Oncogene. 2002 Aug 8;21(34):5193-203. doi: 10.1038/sj.onc.1205706. Oncogene. 2002. PMID: 12149641

5

Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.

Reisman DN, Strobeck MW, Betz BL, Sciariotta J, Funkhouser W Jr, Murchardt C, Yaniv M, Sherman LS, Knudsen ES, Weissman BE. Reisman DN, et al. Among authors: strobeck mw. Oncogene. 2002 Feb 14;21(8):1196-207. doi: 10.1038/sj.onc.1205188. Oncogene. 2002. PMID: 11850839

6

DNA damage invokes mismatch repair-dependent cyclin D1 attenuation and retinoblastoma signaling pathways to inhibit CDK2.

Lan Z, Sever-Chroneos Z, Strobeck MW, Park CH, Baskaran R, Edelmann W, Leone G, Knudsen ES. Lan Z, et al. Among authors: strobeck mw. J Biol Chem. 2002 Mar 8;277(10):8372-81. doi: 10.1074/jbc.M108906200. Epub 2001 Nov 28. J Biol Chem. 2002. PMID: 11726663 Free article.

7

Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.

Strobeck MW, Reisman DN, Gunawardena RW, Betz BL, Angus SP, Knudsen KE, Kowalik TF, Weissman BE, Knudsen ES. Strobeck MW, et al. J Biol Chem. 2002 Feb 15;277(7):4782-9. doi: 10.1074/jbc.M109532200. Epub 2001 Nov 21. J Biol Chem. 2002. PMID: 11719516 Free article.

8

The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression.

Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES. Strobeck MW, et al. J Biol Chem. 2001 Mar 23;276(12):9273-8. doi: 10.1074/jbc.M009747200. Epub 2000 Dec 6. J Biol Chem. 2001. PMID: 11108719 Free article.

9

Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.

Fribourg AF, Knudsen KE, Strobeck MW, Lindhorst CM, Knudsen ES. Fribourg AF, et al. Among authors: strobeck mw. Cell Growth Differ. 2000 Jul;11(7):361-72. Cell Growth Differ. 2000. PMID: 10939590

10

BRG-1 is required for RB-mediated cell cycle arrest.

Strobeck MW, Knudsen KE, Fribourg AF, DeCristofaro MF, Weissman BE, Imbalzano AN, Knudsen ES. Strobeck MW, et al. Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7748-53. doi: 10.1073/pnas.97.14.7748. Proc Natl Acad Sci U S A. 2000. PMID: 10884406 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page